Your browser doesn't support javascript.
loading
Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
Charette, Nicolas; De Saeger, Christine; Lannoy, Valérie; Horsmans, Yves; Leclercq, Isabelle; Stärkel, Peter.
Affiliation
  • Charette N; Laboratory of Gastroenterology, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium.
Mol Cancer ; 9: 256, 2010 Sep 22.
Article in En | MEDLINE | ID: mdl-20860815
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salicylates / Carcinoma, Hepatocellular / Ras Proteins / Farnesol / TOR Serine-Threonine Kinases / Liver Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: Bélgica Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salicylates / Carcinoma, Hepatocellular / Ras Proteins / Farnesol / TOR Serine-Threonine Kinases / Liver Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2010 Document type: Article Affiliation country: Bélgica Country of publication: Reino Unido